BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 16208579)

  • 1. Proteinases as hormone-like signal messengers.
    Hollenberg MD; Houle S
    Swiss Med Wkly; 2005 Jul; 135(29-30):425-32. PubMed ID: 16208579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiology and pathophysiology of proteinase-activated receptors (PARs): proteinases as hormone-like signal messengers: PARs and more.
    Hollenberg MD
    J Pharmacol Sci; 2005 Jan; 97(1):8-13. PubMed ID: 15665444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more.
    Ramachandran R; Hollenberg MD
    Br J Pharmacol; 2008 Mar; 153 Suppl 1(Suppl 1):S263-82. PubMed ID: 18059329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteinases, proteinase-activated receptors (PARs) and the pathophysiology of cancer and diseases of the cardiovascular, musculoskeletal, nervous and gastrointestinal systems.
    Hansen KK; Oikonomopoulou K; Li Y; Hollenberg MD
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Jun; 377(4-6):377-92. PubMed ID: 17952408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Getting the message across: pathophysiology and signaling via receptors for polypeptide hormones and proteinases.
    Hollenberg MD
    Clin Invest Med; 2010 Apr; 33(2):E133. PubMed ID: 20370993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response.
    Steinhoff M; Buddenkotte J; Shpacovitch V; Rattenholl A; Moormann C; Vergnolle N; Luger TA; Hollenberg MD
    Endocr Rev; 2005 Feb; 26(1):1-43. PubMed ID: 15689571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteinase-mediated signaling: proteinase-activated receptors (PARs) and much more.
    Hollenberg MD
    Life Sci; 2003 Dec; 74(2-3):237-46. PubMed ID: 14607251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteinase-mediated cell signalling: targeting proteinase-activated receptors (PARs) by kallikreins and more.
    Oikonomopoulou K; Hansen KK; Saifeddine M; Vergnolle N; Tea I; Diamandis EP; Hollenberg MD
    Biol Chem; 2006 Jun; 387(6):677-85. PubMed ID: 16800728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteinases as hormones: targets and mechanisms for proteolytic signaling.
    Hansen KK; Oikonomopoulou K; Baruch A; Ramachandran R; Beck P; Diamandis EP; Hollenberg MD
    Biol Chem; 2008 Aug; 389(8):971-82. PubMed ID: 18979623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kallikreins and proteinase-mediated signaling: proteinase-activated receptors (PARs) and the pathophysiology of inflammatory diseases and cancer.
    Hollenberg MD; Oikonomopoulou K; Hansen KK; Saifeddine M; Ramachandran R; Diamandis EP
    Biol Chem; 2008 Jun; 389(6):643-51. PubMed ID: 18627296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSCI/RCPSC Henry Friesen Lecture. Mentors and the butterfly effect: triggers for discovering signalling by proteinases via proteinase-activated receptors (PARs) and more.
    Hollenberg MD
    Clin Invest Med; 2012 Feb; 35(6):E378-91. PubMed ID: 23217564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biased signalling and proteinase-activated receptors (PARs): targeting inflammatory disease.
    Hollenberg MD; Mihara K; Polley D; Suen JY; Han A; Fairlie DP; Ramachandran R
    Br J Pharmacol; 2014 Mar; 171(5):1180-94. PubMed ID: 24354792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protease signaling to G protein-coupled receptors: implications for inflammation and pain.
    Dale C; Vergnolle N
    J Recept Signal Transduct Res; 2008; 28(1-2):29-37. PubMed ID: 18437628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostatic trypsin-like kallikrein-related peptidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinase-activated receptors (PARs).
    Ramsay AJ; Reid JC; Adams MN; Samaratunga H; Dong Y; Clements JA; Hooper JD
    Biol Chem; 2008 Jun; 389(6):653-68. PubMed ID: 18627286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteinase-activated receptors (PARs) - focus on receptor-receptor-interactions and their physiological and pathophysiological impact.
    Gieseler F; Ungefroren H; Settmacher U; Hollenberg MD; Kaufmann R
    Cell Commun Signal; 2013 Nov; 11():86. PubMed ID: 24215724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteinase activated receptor (PAR) involvement in mediating arthritis pain and inflammation.
    Russell FA; McDougall JJ
    Inflamm Res; 2009 Mar; 58(3):119-26. PubMed ID: 19184346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteinase-activated receptors, targets for kallikrein signaling.
    Oikonomopoulou K; Hansen KK; Saifeddine M; Tea I; Blaber M; Blaber SI; Scarisbrick I; Andrade-Gordon P; Cottrell GS; Bunnett NW; Diamandis EP; Hollenberg MD
    J Biol Chem; 2006 Oct; 281(43):32095-112. PubMed ID: 16885167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiological actions of protease activated receptors (PARs).
    Pandya NM; Jain SM; Santani DD
    Pharmazie; 2007 Mar; 62(3):163-9. PubMed ID: 17416190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteinase-activated receptor pharmacology: trickier and trickier.
    Moffatt JD
    Br J Pharmacol; 2004 Oct; 143(4):441. PubMed ID: 15381632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protease-activated receptors: how proteases signal to cells to cause inflammation and pain.
    Bunnett NW
    Semin Thromb Hemost; 2006 Apr; 32 Suppl 1():39-48. PubMed ID: 16673265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.